Gamifant 100 MG/20 ML vial 20ML

Ended Awarded

Contract number
SPE2DR26FQRC3
Awardee
Awarding agency
Obligated
$78,674

Award facts

Contract value 100% obligated
$78,673.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 16, 2026, with a ceiling value of $78,673.84 for Gamifant 100 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business serving as the regional prime vendor under PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling and ultimate completion through December 31, 2036. The order is priced on a firm fixed-price basis with an ultimate completion date of July 9, 2026. Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FQRC3?

SPE2DR26FQRC3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 16, 2026.

How much is contract SPE2DR26FQRC3 worth?

The government has obligated $78,674 on SPE2DR26FQRC3.

Is contract SPE2DR26FQRC3 an order under another contract?

Yes. SPE2DR26FQRC3 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.

Was contract SPE2DR26FQRC3 competed?

The extent of competition for SPE2DR26FQRC3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award